Provided by Tiger Trade Technology Pte. Ltd.

Ecopetrol SA

17.75
-0.3200-1.77%
Post-market: 17.920.1677+0.94%19:30 EDT
Volume:1.07M
Turnover:19.00M
Market Cap:36.49B
PE:9.33
High:18.07
Open:17.89
Low:17.54
Close:18.07
52wk High:18.19
52wk Low:8.57
Shares:2.06B
Float Shares:237.00M
Volume Ratio:0.71
T/O Rate:0.45%
Dividend:0.99
Dividend Rate:5.58%
EPS(TTM):1.90
EPS(LYR):1.16
ROE:15.95%
ROA:7.31%
PB:1.78
PE(LYR):15.24

Loading ...

X4 Pharmaceuticals Announces European Commission Approval of XOLREMDI® (Mavorixafor), the First and Only Authorized Treatment for Patients with WHIM Syndrome in the European Union

GlobeNewswire
·
Apr 29

Regeneron Reports First Quarter 2026 Financial and Operating Results

GlobeNewswire
·
Apr 29

Creating a Sustainable Impact: Fosun International Releases 2025 ESG Report and Climate Information Disclosures Report

prnewswire
·
Apr 28

Solid Biosciences receives orphan drug designation for SGT-003 from EC

TIPRANKS
·
Apr 28

Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy

GlobeNewswire
·
Apr 28

Press Release: Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025

Dow Jones
·
Apr 28

Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

GlobeNewswire
·
Apr 28

Novartis announces EC approved Rhapsido for CSU

TIPRANKS
·
Apr 27

EC World REIT Slides Deeper Into Distress as Earnings, Valuations and Distributions Collapse

TIPRANKS
·
Apr 27

Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria

GlobeNewswire
·
Apr 27

Rivelle Tampines EC 100% sold in second round of balloting

Gerine Tang Yi Qian
·
Apr 26

Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)

GlobeNewswire
·
Apr 24

EUA prices: The key variable in Europe’s green steel transition

Fastmarkets
·
Apr 24

Press Release: Ecopetrol enters into an Agreement to acquire an equity stake in Brava Energia S.A. a company domiciled in Brazil

Dow Jones
·
Apr 24

Press Release: Ipsen delivers strong sales in the first quarter of 2026 and confirms its full-year guidance

Dow Jones
·
Apr 23

Moderna receives EC marketing authorization for mCOMBRIAX

TIPRANKS
·
Apr 21

EC Healthcare to Acquire Remaining 10% Stake in Target Company via Put Option

TIPRANKS
·
Apr 21

Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)

prnewswire
·
Apr 20

Ecopetrol Anticipates Copoazú-1 Well Test Results by End of June

Deep News
·
Apr 18

Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

GlobeNewswire
·
Apr 13